NEW PAPER REVEALS HOW ANONYMOUS AGENTS ERASE YEARS OF VACCINE SAFETY AND REPURPOSED DRUG RESEARCH

In one of the first published scientific editorials to directly confront the PubPeer Mob, Dr. Peter McCullough sounds the alarm on how anonymous accusations on PubPeer can escalate into journal investigations, retraction proceedings, and permanent reputational damage, even WITHOUT proven scientific misconduct.

Published in the International Journal of Cardiovascular Research & Innovation, the editorial is titled “Post-publication retraction and the erosion of editorial integrity: A call for adherence to COPE standards.”

Researchers can spend YEARS conducting studies, navigating peer review, and publishing their findings—only to face demands for new references, additional data, or manuscript alterations following weaponized anonymous complaints years later.

THE SCIENTIFIC CENSORSHIP PIPELINE

1. ANONYMOUS SMEAR — PUBPEER

An anonymous agent targets a published scientific paper, triggering formal scrutiny without having to establish scientific misconduct.

2. JOURNAL INTIMIDATION

Editors reopen previously published research, demanding responses, supporting materials, additional references, and manuscript alterations.

3. COERCIVE PRESSURE

Years after publication, scientists face escalating demands for new data, revisions, or concessions—even when the underlying scientific findings have not been demonstrated to be invalid.

4. PUBLIC SHAMING — RETRACTION WATCH

Retraction announcements and subsequent media coverage amplify allegations, inflicting severe reputational damage even without a formal finding of research misconduct.

5. CHILLING EFFECT — SCIENTIFIC CENSORSHIP

Researchers become reluctant to investigate controversial topics, fearing that publishing findings challenging established narratives could jeopardize their reputations, careers, and future research.


Research challenging powerful institutional or commercial interests—including investigations of vaccine safety and repurposed generic drugs—are subjected to disproportionate attacks by the anonymous agents.

Scientific disagreement is NOT scientific misconduct. Questions about references, interpretations, or competing conclusions should generally be resolved through transparent scientific debate, letters to the editor, and appropriate corrections—NOT weaponized retractions.

The editorial calls for enforcement of publication-ethics standards, independent appeals, author protections, and transparency surrounding the funding relationships of organizations involved in the retraction ecosystem.

As Dr. McCullough concludes:

“Post-publication retraction, as currently weaponized, is censorship.”

Scientists should not have to fear that publishing controversial findings will expose them to years of anonymous accusations, reputational attacks, and potentially career-ending proceedings.

Keep reading

‘Virtually No Research’ on 5G Wireless Impact on Human Health

A new systematic review of more than 100 studies concluded there is too little high-quality research on 5G safety to establish whether exposure to the technology harms human health.

The authors, who published their findings on Nov. 4 in the peer-reviewed journal PLOS One, said “controversial discussions” about 5G’s potential health risks led them to conduct the review.

After scouring the published scientific literature for studies on the physiological and health-related effects of 5G-related radiofrequency (RF) radiation and electromagnetic fields (EMFs) in humans and mammals, the authors analyzed 107 studies.

The reviewers found only five studies that explicitly said they examined 5G, but none of them used real-world 5G signals.

They concluded that for most health topics, “the current scientific data were inadequate to draw any conclusions about the physiological and health-related effects of radiofrequency electromagnetic fields in the investigated frequency range of 3-30 GHz.”

“We have virtually no research on the health effects from exposure to 5G wireless technology,” wrote Joel Moskowitz, Ph.D., in a Nov. 10 post on his website about the new review.

Moskowitz directs the Center for Family and Community Health at the University of California, Berkeley, and serves on the International Commission on the Biological Effects of Electromagnetic Fields (ICBE-EMF).

The ICBE-EMF describes itself as a “consortium of scientists, doctors and researchers” who study wireless radiation and recommend wireless radiation exposure guidelines “based on the best peer-reviewed research publications.”

When 5G was first deployed in the U.S. in 2019, telecom industry executives admitted during a U.S. Senate Commerce Committee hearing that they were unaware of any industry-funded independent scientific research on the potential health risks of 5G technology, Moskowitz said.

According to Moskowitz, Sen. Richard Blumenthal (D-Conn.) said during the hearing, “We’re kind of flying blind here, as far as health and safety is concerned.”

Moskowitz wrote, “Unfortunately, we are still flying blind.”

Miriam Eckenfels, director of the Children’s Health Defense (CHD) Electromagnetic Radiation (EMR) & Wireless Program, said, “It is bizarre that we still know so little about the health impacts of a technology that is being rolled out to the point where everyone is exposed to it 24/7.”

Keep reading

Waymo Pulls Robotaxis Off Freeways Nationwide After California Calls Them An ‘Imminent Hazard’

California’s Department of Motor Vehicles has ordered Waymo’s driverless cars off every freeway in the state, saying the robotaxis “pose an imminent hazard to public safety” after they drove into active construction zones and tried to get around a California Highway Patrol traffic break.

The order is dated Nov. 11, but it surfaced only on Tuesday, when the San Francisco Business Times reported it. It restricts both Waymo’s deployment and driverless testing permits, barring the company from running any car without a human driver on a California freeway, and it has no end date: the DMV says it stays in place “until Waymo demonstrates to the Department that it has taken effective corrective actions.”

The order cites three Waymo robotaxis that drove into an active construction closure on US Highway 101 near Burlingame, which the DMV called the latest in a run of construction-zone incursions going back to May 18. Separately, a driverless Waymo on Interstate 280 in San Francisco tried to pass CHP cruisers that were holding traffic back.

Keep reading

Moderna’s mRNA Flu Shot Linked to Surge in Severe Adverse Events, VAERS Data Shows

A new mRNA influenza vaccine from Moderna, approved by the U.S. Food and Drug Administration (FDA) on August 5, has already been linked to 78 reports of adverse events in a federal safety monitoring system.

MFLUSIVA is reportedly a vaccine for active immunization against influenza caused by virus subtypes A and B contained in the vaccine.

But does the vaccine present a greater threat than the influenza it aims to prevent? Reports filed in the Vaccine Adverse Event Reporting System (VAERS) through late October document instances of sudden mobility loss, partial vision impairment, cardiac arrhythmia, syncope, and hospitalization.

BREAKING: Reports of serious injuries and disabilities with Moderna’s new mRNA flu shot have begun to FLOOD the CDC’s Vaccine Adverse Event Reporting System.

Among them are accounts of sudden inability to walk, partial vision loss, cardiac arrhythmias, fainting, and hospitalization.

This hazardous gene therapy should NEVER have been approved.

Here are some of the most concerning cases:

71-year-old woman: Reportedly lost the use of her legs following vaccination.

71-year-old man: Unable to stand or walk approximately 17 hours after vaccination. Remained on the floor for about an hour.

74-year-old woman: Partial vision loss in both eyes, severe headache, fever, and weakness.

Keep reading

‘Risk Far Exceeds the Benefit’: Experts Call for Suspension of Moderna’s mRNA Flu Shot After Reports of Serious Injuries

Within three months of the U.S. Food and Drug Administration’s approval of mFLUSIVA, Moderna’s new mRNA flu vaccine, federal health officials received dozens of adverse event reports, including reports of serious medical events that some experts say raise safety concerns.

An analysis of the Vaccine Adverse Event Reporting System (VAERS) database, managed jointly by the FDA and Centers for Disease Control and Prevention (CDC), identified 78 reports involving mFLUSIVA in September and October.

The data, accurate as of Oct. 30, show that two reports were formally classified as serious, while several others described potentially significant medical problems.

Two reports described people who temporarily lost the ability to walk. One, a 71-year-old man, was flagged for a disability less than a day after vaccination when he experienced shaking arms and leg weakness that left him unable to walk.

In another report, an 84-year-old woman temporarily lost the ability to walk within an hour of vaccination. The woman reported severe weakness and being unable to stand, but the report was not formally classified as serious.

Her initial VAERS report listed her as age 71, but an updated version of the report in VAERS’ raw dataset lists her age as 84.

Other reports described a patient of unknown age hospitalized with fever and low oxygen levels, and a 76-year-old man who reported hallucinations after receiving mFLUSIVA and Moderna’s Spikevax COVID-19 shot.

“There are an alarming number of severe systemic reactions, including high fevers, debilitating fatigue and severe body aches and exhaustion” and a “highly concerning” number of cardiovascular adverse reactions,” said internal medicine physician Dr. Clayton J. Baker.

“This suggests significant systemic toxicity very much akin to the disease the shot is supposedly designed to prevent,” Baker said.

An analysis by The Defender found that, among 58 reports that included information on when symptoms began, 51 indicated that the reactions appeared on the day of vaccination or the following day. Baker said that “from a temporal standpoint, this strongly implicates the shots” as the likely cause of those injuries.

The Defender’s analysis also showed that 37 of the 78 reports noted that the individual received a COVID-19 vaccine around the same time they received Moderna’s mFLUSIVA shot.

Of those, 30 reports indicated that both shots were administered on the same day, while seven described vaccinations on different dates. Two reports also listed an RSV vaccine.

Keep reading

Gene-edited food can reach your plate without a Health Canada safety check, but you’d never know it

Safe Food Matters Inc. and its co-founder, Mary Lou McDonald, have asked the Federal Court to strike down Health Canada guidance that lets many gene-edited plant foods reach the market without the department’s pre-market safety assessment.

The application, filed October 20, names the Attorney General of Canada. It asks the court to declare the May 18, 2022, Guidance on the Novelty Interpretation of Products of Plant Breeding unlawful and contrary to section 7 of the Charter, and to quash its key section.

The court has not ruled yet, but under the Food and Drug Regulations, a food is “novel” if it comes from a plant “genetically modified” to gain or lose a characteristic. Novel foods need Health Canada’s written clearance before sale. The 2022 guidance carves out an exception: if a gene-edited plant contains no foreign DNA and meets four other criteria, it’s not novel.

That means there’s no mandatory notification, no departmental assessment and no public decision.

McDonald says in the filing that she refuses genetically modified foods as a matter of health and conscience and “cannot reliably determine whether the foods offered to her are gene-edited.” She put it plainly: “the only filter I had to protect my health from GE food was transparency from Health Canada. That protection is gone.”

The applicants argue that a guidance document can’t rewrite a regulation. Health Canada says it still assesses all novel foods and has no authority to require notice of products it doesn’t consider novel.

Basically, disclosure is voluntary. Health Canada’s list of non-novel products names 25 products, 15 of them gene-edited, including tomatoes, potatoes, strawberries, corn and soybeans. The newest is dated July 31, 2026, and Canada doesn’t require labels identifying genetic modification or gene editing at all, unless there’s a health reason (like an allergen).

The same light touch now covers seed. Since May 2023, CFIA guidance generally exempts gene-edited plants without foreign DNA from pre-release authorization. In most cases, developers decide for themselves whether their plant is novel.

Who wanted it this way? Radio-Canada reported in September 2023 that access-to-information records showed a government-industry “Tiger Team,” including CropLife Canada, helped shape the approach.

Keep reading

Needle-Free mRNA Vaccine With Aluminum Protects Mice Against COVID and Flu — But Study Lacks Safety Data

Scientists have developed a needle-free mRNA vaccine that protects mice against COVID-19 and flu and causes less inflammation than conventional formulations, according to a new study published in The Journal of Clinical Investigation.

The vaccines use a high-pressure liquid jet to deliver genetic material directly through the skin, unlike the Pfizer-BioNTech and Moderna COVID-19 shots, which use lipid nanoparticles as the delivery system.

The authors — researchers from Rutgers University and Japanese institutions — reported that the technology generated strong immune responses and reduced viral replication in vaccinated mice.

The vaccine hasn’t been tested in humans, and researchers haven’t established whether it could reduce serious adverse reactions.

“Showing that a carrier-free, needle-free vaccine can be made protective opens a different design space than the one the field has been working in,” said study co-author Renata Pasqualini, Ph.D., a Rutgers researcher, in a university announcement.

COVID vaccines linked to serious adverse events

The study comes amid continuing concerns about COVID-19 vaccine injuries, and a study released this week comparing Pfizer and Moderna vaccine mortality rates.

The Centers for Disease Control and Prevention (CDC) has recognized a causal link between mRNA COVID-19 vaccines and myocarditis and pericarditis, particularly among adolescent and young adult males.

A 2022 study published in JAMA identified 1,626 reports meeting the CDC’s case definition for myocarditis following mRNA vaccination during the study period.

Reporting rates were highest among adolescent boys after their second dose, reaching approximately 106 cases per million Pfizer doses among males ages 16 and 17.

Symptoms of myocarditis can include chest pain, shortness of breath and an irregular heartbeat. Although many patients recover, some require hospitalization, and others have reported being permanently disabled.

Other documented serious adverse reactions include anaphylaxis following vaccination and a rare blood-clotting disorder associated with Johnson & Johnson’s COVID-19 vaccine.

The federal Vaccine Adverse Event Reporting System (VAERS) collects reports of suspected vaccine injuries and deaths. The latest figures show 1,678,901 adverse event reports following COVID-19 vaccination submitted to VAERS as of Sept. 25, 2026, including 39,260 reported fatalities and 29,299 reports of myocarditis or pericarditis.

The Rutgers study did not investigate whether its mRNA needle-free vaccine could prevent serious injuries.

Keep reading

Nearly 1,900 U.S. Schools Are Within 1 Mile of an AI Data Center, Prompting Health Concerns for Children

Researchers warn that air pollution, industrial noise and 24/7 artificial light emitted by AI data centers could threaten children’s health and contribute to learning difficulties. Large data centers can house hundreds of diesel-powered generators, which can release nitrogen oxides, carbon monoxide and fine particulate matter.

Nearly 1,900 public schools in the U.S. are located within a mile of existing or proposed data centers, prompting concerns among researchers, educators and parents about potential health risks stemming from the artificial intelligence (AI) industry’s rapid expansion.

Research highlighted by the National Education Association identified 1,878 public schools within a mile of data centers, including 602 in California and 101 in Virginia.

The findings come as researchers examine the environmental consequences of a booming AI sector whose electricity demands are expected to increase drastically in the coming years.

A 2024 study conducted by the University of California, Riverside, and California Institute of Technology looked at prospective effects of the industry’s growth. Researchers estimated that air pollution associated with AI infrastructure could contribute to as many as 1,300 premature deaths annually in the U.S. by 2030, with public health costs approaching $20 billion.

The projections account for pollution — including fine particulate matter linked to respiratory and cardiovascular diseases — from electricity generation and diesel backup generators.

“If you look at those sustainability reports by tech companies, they only focus on carbon emissions, and some of them include water as well, but there’s absolutely no mention of unhealthful air pollutants. And these pollutants are already creating a public health burden,” said Shaolei Ren, Ph.D., a UC Riverside engineering professor and study co-author.

Although research directly linking data center proximity to specific illnesses among schoolchildren remains limited, studies examining other sources of industrial pollution have documented significant consequences for children’s health and education.

A 2026 study published in the Proceedings of the National Academy of Sciences found that nearly 10,000 U.S. schools, enrolling 3.36 million students, are located within a quarter-mile of known environmental hazard sites. About 44% of schools are within a mile of at least one site.

The study specifically examined Superfund sites, contaminated former industrial properties known as brownfields, and facilities that report toxic chemical releases to the U.S. Environmental Protection Agency (EPA).

“The location of schools relative to these hazards has direct implications for children’s development and learning given the well-documented negative health and academic effects of exposure to pollution,” the researchers wrote.

Researchers cautioned that their findings likely underestimate the number of schools potentially exposed to hazardous pollutants because the analysis excluded several pollution sources.

Diesel generators linked to asthma attacks, reduced lung function in kids

A major concern with the spread of AI data centers is their reliance on diesel-powered backup generators, which can release nitrogen oxides, carbon monoxide and fine particulate matter.

Large facilities can house hundreds of generators intended to maintain operations during power outages. Their emissions depend on factors including generator capacity, operating hours, fuel use and pollution controls.

The EPA has linked pollution from generators to asthma attacks, reduced lung function and impaired lung development in children.

Kids are particularly vulnerable to air pollution because their lungs and other organs are still developing.

Keep reading

Savannah River Site Lifts Emergency After Lab Fire And Reported Radiological Release

A fire in a single room at the Savannah River National Laboratory triggered a Site Area Emergency at the US Department of Energy complex on the South Carolina side of the Savannah River from Augusta late this Wednesday. Site officials reported the fire had been brought under control, with no contamination reported outside the affected building, and said the operational emergency was over by 9:18 p.m.

WRDW reported that the site described an “unfiltered ground-level radiological release” from that room. WRDW reports that dispatch traffic and an SRS release have found no indication of contamination beyond the site boundary. Officials at the lab have told the station that there is no danger to the public outside of the reservation.

SRS closed entrance barricades to incoming traffic. Rail, river, and air traffic was also temporarily restricted. Employees not involved in the incident were told to go to shelter. Workers in the lab, located in Area A, were kept behind the barricades for approximately 30 minutes before some were allowed to leave, WRDW reported. A temporary flight restriction (TFR) was put in place by the FAA until midnight Thursday. The restriction is for a 15-nm radius around SRS with a flight ceiling of 10,000 feet.

All-clear posted on the SRS status page at 9:18 p.m. There are no operational emergencies or scheduled delays. Incoming and outgoing traffic has resumed at all barricades, and oncoming shift workers should report to work as usual.

Savannah River Site is a 310-square-mile reservation in Aiken, Barnwell and Allendale counties on the SC side of the Savannah River which forms the Georgia line. Augusta sits on the Georgia side. The complex is home to the Department of Energy’s national laboratory conducting nuclear materials research in support of its environmental cleanup and nuclear waste management mission as well as the production of tritium in support of the country’s nuclear deterrent. The site was built in the early 1950s to produce plutonium and later tritium for nuclear weapons, WRDW reported.

SRS has not yet issued a follow-up press release to describe the extent of radioactive material release from the single room where the fire occurred. Their initial release states that the fire has been extinguished and that there has been no report of contamination outside of the lab building. The operational emergency ended Wednesday night.

Keep reading

Vaccine Injury: A Glimpse of the Scale

Ihave heard these stories a thousand times. I am a board‑certified pediatrician with 46 years of clinical experience. I’ve practiced in group and solo settings, served as Director of Pediatric Education for a residency program, and received numerous awards for child‑health initiatives. My solo practice had 3,500 general pediatric patients. I spent five years as Medical Director of the Autism Research Institute.

By caring for and consulting on more than 600 children with autism from 5 countries and 20 states, and hundreds of children with complex chronic illnesses, I have a unique clinical perspective to share, which mirrors what these families shared today.

My concerns about vaccine safety began in 1999 after my patient experienced a severe and irreversible reaction following a vaccine I gave. Despite exhaustive efforts to identify another cause, I could not. The trajectory of my career changed. I left a secure academic position I loved and opened a solo practice dedicated to children whose medical needs were not being met.

During my career I learned an extraordinary amount from parents who are usually perceptive observers of their children’s health. At ARI we partnered with families to identify medical problems that were overlooked. Their insights guided our research and these actions should guide our actions today. Families directed us to treat gastrointestinal dysfunction, immune dysregulation, and impairments in detoxification pathways. Collaborations with international scientists helped identify mitochondrial dysfunction, methylation abnormalities, cerebral folate deficiency, and prolonged cell danger responses.

Most pediatricians do not know about these issues. Addressing these problems often resulted in measurable improvements in autism symptoms. Some children initially diagnosed with moderate to severe autism entered kindergarten no longer meeting criteria for autism because their medical problems were treated. Other severely affected children treated as toddlers have gone on to college without knowing they once carried an autism diagnosis.

My concerns about vaccine safety extend far beyond the narrow question of whether vaccines cause autism. Autism and complex chronic illnesses are profoundly heterogeneous. In my experience, antecedents, mediators, and triggers vary widely among children. Vaccines contribute to oxidative or mitochondrial stress in all children. In some kids; they amplify pre‑existing vulnerabilities. For others, early-life factors—such as C‑section birth, antibiotics, or prematurity — create antecedent conditions that interact with later vaccines and precede neurodevelopmental regression.

In 2005, I gave grand rounds at the university where I had been chief resident. Simply raising the possibility that the accelerated vaccine schedule might contribute to rising autism prevalence resulted in my adjunct faculty appointment not being renewed. At the time, I used a modified schedule that reduced aluminum exposure while remaining fully compliant with Virginia’s school requirements.

In 2006, I met with AAP leadership to discuss vaccine safety concerns – which were dismissed. Despite no research funding from government or pharma, I published a dozen studies in my spare time. One 17‑year project examined whether autism risk could be reduced by applying insights learned from families. After seven years, my autism prevalence was 1 in 297—at a time when the national rate was worse than 1 in 50. I submitted the findings to the AAP in 2013, expecting interest in a six‑fold reduction in such a serious public health problem. I received no response.

Keep reading